CoV N-Mosaic

  • Product Code: SARS-015
  • Synonyms/Product Alternate Names: Coronavirus 2019 Nucleocapsid Mosaic Recombinant
  • Please allow 2-3 weeks average availability

    A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV or COVID-19 ( was found in the city of Wuhan, Hubei province of China on December 2019.

    The 2019-nCoV (SARS-CoV-2) shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity, thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.

    RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

    The E. coli derived recombinant protein contains the Coronavirus 2019 full length nuclepocapsid Mosaic immunodominant regions [ full length N-antigen ], fused to His tag at C-terminal.

    Physical Appearance: Sterile Filtered clear solution.

    Formulation: CoV 2019 Nucleocapsid-Mosaic Protein 1mg/ml solution is supplied in 1x PBS.

    Stability:CoV 2019 Nucleocapsid-Mosaic Protein is shipped on ice packs. Upon arrival, store at -20°C.

    Find other coronavirus products and news here.


  • Origin: Escherichia coli
  • Storage Conditions: -20 ℃
  • Purity: >90% pure as determined SDS-PAGE

Delivery Details: All quantities are subject to availability. Please allow 7-10 days for delivery.

  • 50µg
  • $150.00
  • 250µg
  • $600.00
  • 1000µg
  • $1,600.00
For research use ONLY. Not for use on humans.